Hyperthermia Cancer Treatment Market Report 2026

Hyperthermia Cancer Treatment Market Overview

• Hyperthermia Cancer Treatment market size has reached to $0.29 billion in 2025 • Expected to grow to $0.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Surge In Global Cancer Incidence Fueling The Growth Of The Market Due To Increasing Aging Population Leading To Higher Cancer Diagnosis Rates • Market Trend: Integration Of AI And Imaging Technologies Transforming Thermal Cancer Therapy Approaches • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hyperthermia Cancer Treatment Market?

Hyperthermia cancer treatment is a medical therapy that uses controlled heat to raise the temperature of tumor tissues and damage or destroy cancer cells. It is often used together with treatments such as radiation therapy, chemotherapy, or immunotherapy to improve their effectiveness. The treatment can be applied locally, regionally, or to the whole body depending on the type and location of the cancer. The main device types of hyperthermia cancer treatment include microwave hyperthermia device, ultrasound hyperthermia device, infrared hyperthermia device, and short-wave hyperthermia device. Microwave hyperthermia device refers to a medical system that uses controlled microwave energy to raise tumor tissue temperature to enhance cancer treatment effectiveness. These devices are used across applications including breast cancer, liver cancer, soft tissue sarcoma, leukemia, head and neck tumors, prostate cancer, and others, and are utilized by end users including hospitals, cancer treatment centers, and research organizations.

What Is The Hyperthermia Cancer Treatment Market Growth Forecast?

The hyperthermia cancer treatment market size is expected to see strong growth in the next few years. It will grow to $0.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising demand for precision oncology and personalized treatment approaches, increasing adoption of combination cancer therapies, growth in non invasive and targeted treatment technologies, expansion of healthcare infrastructure in emerging economies, increasing investment in medical device innovation for cancer care. Major trends in the forecast period include increasing adoption of image guided hyperthermia treatment systems for precise tumor targeting, rising integration of ai based treatment planning for optimized thermal dose delivery, growth in combination therapies using hyperthermia with radiation and chemotherapy, expansion of minimally invasive and localized cancer heating techniques, increasing use of real time temperature monitoring and feedback control systems in oncology treatment.

Global Hyperthermia Cancer Treatment Market Segmentation

1) By Device Type: Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, Short-Wave Hyperthermia Device 2) By Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Leukemia, Head And Neck Tumors, Prostate Cancer, Other Applications 3) By End User: Hospitals, Cancer Treatment Centers, Research Organizations Subsegments: 1) By Microwave Hyperthermia Device: Superficial Tissue Heating, Deep Tissue Heating, Regional Microwave Hyperthermia, Interstitial Microwave Heating 2) By Ultrasound Hyperthermia Device: High Intensity Focused Ultrasound Heating, Therapeutic Ultrasound Heating, Focused Deep Tissue Heating, Interstitial Ultrasound Heating 3) By Infrared Hyperthermia Device: Superficial Infrared Heating, Near Infrared Therapy Heating, Localized Surface Heating, Whole Body Infrared Heating 4) By Short-Wave Hyperthermia Device: Capacitive Coupling Heating, Inductive Short-Wave Heating, Regional Short-Wave Hyperthermia, Deep Tissue Short-Wave Heating

What Is The Driver Of The Hyperthermia Cancer Treatment Market?

The rising global cancer incidence is expected to propel the growth of the hyperthermia cancer treatment market going forward. Cancer incidence refers to the number of new cancer cases diagnosed within a specific population during a defined period of time. The increase in global cancer incidence is primarily driven by population aging, as longer life expectancy results in a larger proportion of individuals reaching ages where cancer risk is significantly higher. Hyperthermia cancer treatment supports cancer care by enhancing tumor sensitivity to conventional therapies such as radiation and chemotherapy while reducing systemic toxicity and side effects. For instance, in October 2025, according to the National Library of Medicine, a US-based government agency, global cancer incidence is projected to increase by 60.7% between 2024 and 2050, rising from 19.0 million new cases to 30.5 million cases over the forecast period. Therefore, the rising global cancer incidence is driving the growth of the hyperthermia cancer treatment industry.

Key Players In The Global Hyperthermia Cancer Treatment Market

Major companies operating in the hyperthermia cancer treatment market are Chongqing Haifu Medical Technology Co. Ltd, InSightec Ltd., Profound Medical Corp., FocalTherics, Yamamoto Vinita Co. Ltd., Pyrexar Medical Inc., Sonablate Corp., Oncotherm Kft, Celsius42 GmbH, Clinical Laserthermia Systems AB, Theraclion SA, RanD S.r.l., Combat Medical Ltd., Sensius B.V., Dr. Sennewald Medizintechnik GmbH, Med-Logix SRL, Heckel Medizintechnik GmbH, Hydrosun GmbH, Therma Solutions Inc., Elmedical Ltd., NovaFlux Technologies, ThermaMed GmbH

Global Hyperthermia Cancer Treatment Market Trends and Insights

Major companies operating in the hyperthermia cancer treatment market are focusing on developing advanced solutions, such as AI-assisted image-guided thermal targeting platforms, to improve precision tumor heating through real-time imaging feedback and controlled thermal dose delivery. AI-assisted image-guided thermal targeting platforms are systems that combine artificial intelligence with real-time medical imaging to precisely direct and control therapeutic heat delivery to specific tissues, improving treatment accuracy and safety. For instance, in March 2026, New Phase Ltd., an Israel-based medical technology company, launched the SARAH Nanoparticle Electromagnetic Hyperthermia Platform, which enables targeted tumor heating up to 50°C using magnetically activated nanoparticles under electromagnetic induction. It enhances selective destruction of cancer cells while preserving normal tissue integrity, and provides a non-invasive, repeatable treatment approach with reduced systemic toxicity compared to conventional chemotherapy and radiation therapy.

What Are Latest Mergers And Acquisitions In The Hyperthermia Cancer Treatment Market?

In February 2026, Mayo Clinic, a US-based medical research and healthcare institution, partnered with New Phase Ltd. to advance early-stage clinical research. With this partnership, Mayo Clinic aims to advance early-stage clinical evaluation, and validation of nanoparticle-based electromagnetic hyperthermia therapy for the treatment of advanced-stage cancers, while assessing its safety, tumor-targeting efficiency, and potential to improve outcomes compared to conventional oncology treatments, supporting the development of next-generation hyperthermia cancer treatment technologies. New Phase Ltd. is an Israel-based medical technology company specializing in nanoparticle-based electromagnetic hyperthermia systems for cancer therapy.

Regional Outlook

North America was the largest region in the hyperthermia cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hyperthermia Cancer Treatment Market?

The hyperthermia cancer treatment market consists of revenues earned by entities by providing services such as localized hyperthermia therapy for tumor treatment, whole-body hyperthermia, combination therapy with radiotherapy or chemotherapy, treatment planning, and temperature monitoring during therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperthermia cancer treatment market also includes sales of deep regional hyperthermia systems, interstitial hyperthermia applicators, endocavity hyperthermia applicators, and thermal therapy probes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hyperthermia Cancer Treatment Market Report 2026?

The hyperthermia cancer treatment market research report is one of a series of new reports from The Business Research Company that provides hyperthermia cancer treatment market statistics, including hyperthermia cancer treatment industry global market size, regional shares, competitors with a hyperthermia cancer treatment market share, detailed hyperthermia cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperthermia cancer treatment industry. This hyperthermia cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.